Visual acuity outcomes after repair of uncomplicated rhegmatogenous retinal detachments
April 18th 2023Vit-Buckle Society
Dr Ong and colleagues undertook a retrospective study of patients who underwent primary repair of uncomplicated RRDs at the Wilmer Eye Institute to examine the baseline, surgical, and postoperative characteristics that affect best-corrected VA (BCVA) outcomes.
Considering retinal detachments and predictors of poor visual outcomes after repair
April 15th 2023Vit-Buckle Society
Sally S. Ong, MD, shares the key takeaways from her presentation, Predictors of Poor Visual Outcome After Repair of Uncomplicated Rhegmatogenous Retinal Detachments, at the 11th Annual Vit-Buckle Society meeting.
Findings from the Persimmon Study for macula-off retinal detachments
April 15th 2023Vit-Buckle Society
Sean D. Adrean MD, FAAO, discusses the key takeaways from his presentation, Purposeful Pneumatic Induced Resorption of Submacular Fluid in Macula-off Retinal Detachments, at the 11th Annual Vit-Buckle Society meeting, April 13 to 15, in Las Vegas, Nevada.
Jennifer Lim shares research on vitrectomy combined with KPro surgery
April 14th 2023Vit-Buckle Society
Jennifer Lim, MD, FARVO joined David Hutton, Managing Editor, Ophthalmology Times®, to discuss her presentation on keratoprosthesis combined with vitrectomy surgery given at this year's Vit-Buckle Society meeting.
ARVO 2023: Opportunities to enjoy social/networking events
April 13th 2023ARVO
The 2023 Association for Research in Vision and Ophthalmology (ARVO) annual meeting promises to provide numerous opportunities to meet up with old friends and colleagues and forge relationships with new ones as well as enhance future research and practice endeavors.
ARVO 2023: Celebrating the beauty of diversity in science and nature
April 12th 2023ARVO
The Association for Research in Vision and Ophthalmology (ARVO) 2023 annual meeting is convening in New Orleans from April 23 to 27 at the Ernest N. Morial Convention Center. The theme of the Annual Meeting speaks both to the mechanistic diversity in ocular disease in addition to the diversity of vision scientists who are from multiple backgrounds and perspectives.
COPHy 2023: Debating the value of home monitoring as a management option for AMD
March 25th 2023COPHy
The various aspects of home monitoring for patients with age-related macular degeneration are discussed in this point/counterpoint by Prof. Rufino Silva, University of Coimbra / Coimbra Hospital and University Centre, Portugal, and Univ.-Prof. Dr. med. Robert P. Finger, PhD, Department of Ophthalmology, University of Bonn, Germany, during the 14th annual Congress on Controversies in Ophthalmology in Lisbon, Portugal.
COPHy 2023: Weighing the merits of offering teprotumumab for all patients with thyroid eye disease
March 25th 2023COPHy
Pedro Fonseca, MD, Coimbra Hospital and University Centre, Portugal, and Andrew G. Lee, MD, Blanton Eye Institute, Houston Methodist, Texas, USA, discuss the various pros and cons of offering teprotumumab for all patients with thyroid eye disease.
COPHy 2023: New restorative therapies
March 24th 2023COPHy
In a keynote lecture at the 14th Annual Congress on Controversies in Ophthalmology in Lisbon, Hendrik Scholl, MD, co-founder and director of the Institute of Molecular and Clinical Ophthalmology Basel, discussed its mission to unravel the mysteries of vision and human eye disease.
APAO 2023: Beveled tip probe added to arsenal for retinal detachment vitrectomy
February 24th 2023APAO
Yusuke Oshima, MD, PhD, in a presentation at the 38th Asia-Pacific Academy of Ophthalmology Congress, Kuala Lumpur, Malaysia, discussed the advantages of using a beveled-tip ultra-speed probe for complete vitreous shaving during retinal detachment vitrectomies.
APAO 2023: Step therapy from Bevacizumab to Aflibercept for DME
February 24th 2023APAO
Voraporn Chaikitmongkol, MD, discussed step therapy and reported the results of a major study, the Diabetic Retinopathy Clinical Research (DRCR) Protocol AC, at the 38th Asia-Pacific Academy of Ophthalmology Congress, in Kuala Lumpur, Malaysia.
APAO 2023: Looking at anatomic outcomes in matched comparison: TENAYA and LUCERNE data
February 23rd 2023APAO
Greater anatomic improvements (central subfield thickness reduction, proportion with absence of subretinal fluid and intraretinal fluid) were seen with faricimab versus aflibercept during the matched dosing period (week 4, week 8, and week 12).
Networking and social activities abound for APAO delegates
February 15th 2023APAO
The agenda includes the Opening Ceremony, Women in Ophthalmology Luncheon, and Young Ophthalmologists’ Night, and that's only a sampling. The results of the APAO-Asia-Pacific Ocular Imaging Competition will also be announced.
Angiogenesis 2023: Talon Phase 3b study results: brolucizumab vs aflibercept
February 10th 2023Angiogenesis
Carl D. Regillo, MD, highlights the Talon Phase 3b results for brolucizumab vs aflibercept in a matched treat-and-extend superiority study for neovascular AMD at the virtual 2023 Angiogenesis conference.
Angiogenesis 2023: Ellipsoid zone integrity in dry AMD
February 10th 2023Angiogenesis
In a presentation at the Angiogenesis, Exudation, and Degeneration 2023 conference, Justis Ehlers, MD, presented "Ellipsoid Zone Integrity in Dry AMD: An Imaging Biomarker for Progression Risk and Clinical Trial Endpoint.”